Skip to main content
. 2023 Feb 14;9(3):1450–1459. doi: 10.1021/acsbiomaterials.2c01504

Table 2. Excipients Used for SEDDS Development (* Oil, ** Oil/Co-surfactant, *** Surfactant) and Composition of SEDDS Formulations [%, v/v] (HLB: Hydrophilic–Lipophilic Balance).

    SEDDS formulation
Excipient HLB F1 F2 F3
Medium chain triglycerides * (Labrafac lipophile WL 1349) 1 10 30 50
Oleyl alcohol ** 14 50 30 10
Kolliphor EL *** (PEG-35 castor oil) 12–14 20 20 40
Tween 80 *** (Polyoxyethylene (20) sorbitan monooleate) 16.7–17 20 20